{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:52:02Z","timestamp":1793040722859,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabolic syndrome (MetS) is a growing public health concern worldwide. It has been demonstrated that individuals with MetS are at an increased risk of cardiovascular events and diabetes. We aimed to investigate the prevalence of MetS and its components among Turkic and Kurds ethnic groups in a bi-ethnic (Turk and Kurd) population. This cross-sectional study is part of the national health transformation plan created in response to the emerging epidemic of non-communicable diseases (Iran\u2019s Package of Essential Non-communicable Disease study), launched in 2014 in Naqadeh, Iran. In total, 3506 participants aged 30\u201370 years were randomly included in the study from urban and rural regions. Cardio-metabolic risk factors related to MetS diagnosis and other related sociodemographic factors were assessed for men and women in both the Turk and the Kurd population. Multivariate logistic regressions were applied to identify MetS -associated factors among both the Turk and the Kurd population. The mean (SD) age of the participants was 49.6 (12.3) years. Of the participants, 56.2% (n\u2009=\u20091969) were women, and 43.8% (n\u2009=\u20091537) were men. Three-fifths of the participants were Turk (60.3%, n\u2009=\u20091751). The overall prevalence of MetS was 37.05%, with a higher prevalence in women (49.8% versus 24.3% in men). The prevalence of MetS and its components among Turk people (41.6%) were significantly higher than that among Kurd people (33.9%) (p\u2009&lt;\u20090.0001). In addition, the prevalence of MetS was higher among women, urban, and older people for both ethnicities. Strong associations were found between MetS prevalence and being older, being female, being overweight, being obese, having a higher waist-to-hip ratio, and having a history of diabetes and cardiovascular disease (CVD) in the family for both Turks and Kurds. The raised waist circumference (WC) is the most prevalent MetS component for Turk men and women. Meanwhile, the most prevalent MetS component for Kurd participants is low high-density lipoprotein for women and a raised WC for men. Significant differences were found between Kurdish men and women for all components, except for a raised WC and a raised fasting blood glucose (p\u2009&lt;\u20090.05). Because the Iranian population features multiple ethnicities, the recognition of the prevalence of MetS components is a major step in establishing intervention strategies for modifying cardio-metabolic risk factors based on the population ethnicities and their socio-demographic, cultural, and lifestyle factors. We recommend future studies for planning an efficient and sustainable health education and promotion program to halt MetS prevalence.<\/jats:p>","DOI":"10.1038\/s41598-019-44486-8","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:04:40Z","timestamp":1559037880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Prevalence of metabolic syndrome and its determinants among Iranian adults: evidence of IraPEN survey on a bi-ethnic population"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0491-5764","authenticated-orcid":false,"given":"Leila","family":"Jahangiry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Khosravi-far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Sarbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Kousha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasool","family":"EntezarMahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Ponnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"44486_CR1","doi-asserted-by":"crossref","unstructured":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 (2002).","DOI":"10.1161\/circ.106.25.3143"},{"key":"44486_CR2","unstructured":"Grundy, S. M. et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol. 44 (2004)."},{"issue":"9491","key":"44486_CR3","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KGM Alberti","year":"2005","unstructured":"Alberti, K. G. M., Zimmet, P. & Shaw, J. The metabolic syndrome\u2014a new worldwide definition. The Lancet. 366(9491), 1059\u201362 (2005).","journal-title":"The Lancet."},{"key":"44486_CR4","first-page":"285","volume":"2001","author":"J Cleeman","year":"2001","unstructured":"Cleeman, J. et al. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III). JAMA. 2001, 285 (2001).","journal-title":"JAMA."},{"issue":"17","key":"44486_CR5","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy, S. M. et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation. 112(17), 2735\u201352 (2005).","journal-title":"Circulation."},{"key":"44486_CR6","doi-asserted-by":"crossref","unstructured":"Agyemang, C. et al. Hypertension control in a large multi-ethnic cohort in Amsterdam, The Netherlands: The HELIUS study. Int J Cardiol (2015)","DOI":"10.1016\/j.ijcard.2015.01.061"},{"key":"44486_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0147601","volume":"11","author":"P Modesti","year":"2016","unstructured":"Modesti, P. et al. Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PloS one. 11, 1 (2016).","journal-title":"PloS one."},{"key":"44486_CR8","doi-asserted-by":"crossref","unstructured":"Agyemang, C. et al. Ethnicity and cardiovascular health research: pushing the boundaries by including comparison populations in the countries of origin. Ethn Health. (2012).","DOI":"10.1080\/13557858.2012.730607"},{"issue":"4","key":"44486_CR9","first-page":"456","volume":"46","author":"S Dalvand","year":"2017","unstructured":"Dalvand, S. et al. Prevalence of Metabolic Syndrome among Iranian Population: A Systematic Review and Meta-analysis. Iranian Journal of Public Health. 46(4), 456\u201367 (2017).","journal-title":"Iranian Journal of Public Health."},{"issue":"9","key":"44486_CR10","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.nut.2005.01.007","volume":"21","author":"A Misra","year":"2005","unstructured":"Misra, A. et al. Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. Nutrition. 21(9), 969\u201376 (2005).","journal-title":"Nutrition."},{"key":"44486_CR11","doi-asserted-by":"crossref","unstructured":"Esteghamati, A. et al. Optimal waist circumference cut-offs for the diagnosis of metabolic syndrome in Iranian adults: results of the third national survey of risk factors of non-communicable diseases (SuRFNCD-2007). Diabet Med. 26 (2009).","DOI":"10.1111\/j.1464-5491.2009.02756.x"},{"key":"44486_CR12","unstructured":"Delavar, M. A. et al. Dietary patterns and the metabolic syndrome in middle aged women, Babol. Iran Asia Pac J Clin Nutr. 18 (2009)."},{"key":"44486_CR13","unstructured":"Azizi, F. et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med. 13 (2010)"},{"key":"44486_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.pmedr.2017.07.004","volume":"7","author":"PB Nolan","year":"2017","unstructured":"Nolan, P. B. et al. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis. Preventive medicine reports. 7, 211\u20135 (2017).","journal-title":"Preventive medicine reports."},{"key":"44486_CR15","doi-asserted-by":"crossref","unstructured":"Azizi, F. et al. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 61 (2003)","DOI":"10.1016\/S0168-8227(03)00066-4"},{"key":"44486_CR16","unstructured":"WorldAtlas.com LEGII, https:\/\/www.worldatlas.com\/articles\/largest-ethnic-groups-in-iran.html."},{"key":"44486_CR17","unstructured":"https:\/\/en.wikipedia.org\/wiki\/Naqadeh_County."},{"key":"44486_CR18","unstructured":"http:\/\/www.who.int\/news-room\/feature-stories\/detail\/islamic-republic-of-iran-on-a-fast-track-to-beating-noncommunicable-diseases."},{"key":"44486_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti, K. G., Zimmet, P. & Shaw, J. Metabolic syndrome\u2013a new world-wide definition. A Consensus Statement from the InternationalDiabetes Federation. Diabet Med 23, 469\u2013480 (2006).","journal-title":"Diabet Med"},{"issue":"3","key":"44486_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.dsx.2014.04.012","volume":"8","author":"K Hajian-Tilaki","year":"2014","unstructured":"Hajian-Tilaki, K. et al. Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: A population-based study. Diabetes & Metabolic Syndrome. Clinical Research & Reviews. 8(3), 170\u20136 (2014).","journal-title":"Diabetes & Metabolic Syndrome. Clinical Research & Reviews."},{"issue":"5","key":"44486_CR21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/1753-0407.12438","volume":"9","author":"S Noshad","year":"2017","unstructured":"Noshad, S. et al. Prevalence of metabolic syndrome in Iran: A 2011 update. Journal of Diabetes. 9(5), 518\u201325 (2017).","journal-title":"Journal of Diabetes."},{"issue":"7","key":"44486_CR22","first-page":"77","volume":"41","author":"N Esmailnasab","year":"2012","unstructured":"Esmailnasab, N. et al. Risk Factors of Non-Communicable Diseases and Metabolic Syndrome. Iranian Journal of Public Health. 41(7), 77\u201385 (2012).","journal-title":"Iranian Journal of Public Health."},{"issue":"2","key":"44486_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.diabres.2006.12.001","volume":"77","author":"A Zabetian","year":"2007","unstructured":"Zabetian, A. et al. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Research and Clinical Practice. 77(2), 251\u20137 (2007).","journal-title":"Diabetes Research and Clinical Practice."},{"issue":"2","key":"44486_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.diabres.2010.03.010","volume":"89","author":"M Ravikiran","year":"2010","unstructured":"Ravikiran, M. et al. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes research and clinical practice. 89(2), 181\u20138 (2010).","journal-title":"Diabetes research and clinical practice."},{"issue":"8","key":"44486_CR25","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.metabol.2009.04.008","volume":"58","author":"H Zuo","year":"2009","unstructured":"Zuo, H. et al. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism. 58(8), 1102\u20138 (2009).","journal-title":"Metabolism."},{"issue":"5","key":"44486_CR26","doi-asserted-by":"publisher","first-page":"e0125615","DOI":"10.1371\/journal.pone.0125615","volume":"10","author":"S-Y Park","year":"2015","unstructured":"Park, S.-Y. et al. Normal Range Albuminuria and Metabolic Syndrome in South Korea: The 2011\u20132012 Korean National Health and Nutrition Examination Survey. PLoS ONE. 10(5), e0125615 (2015).","journal-title":"PLoS ONE."},{"issue":"2","key":"44486_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.dsx.2017.11.004","volume":"12","author":"A Ansarimoghaddam","year":"2018","unstructured":"Ansarimoghaddam, A. et al. Prevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 12(2), 195\u2013201 (2018).","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews."},{"issue":"3","key":"44486_CR28","doi-asserted-by":"publisher","first-page":"e0192372","DOI":"10.1371\/journal.pone.0192372","volume":"13","author":"S Harikrishnan","year":"2018","unstructured":"Harikrishnan, S. et al. Prevalence of metabolic syndrome and its risk factors in Kerala, South India: Analysis of a community based cross-sectional study. PLOS ONE. 13(3), e0192372 (2018).","journal-title":"PLOS ONE."},{"key":"44486_CR29","doi-asserted-by":"crossref","unstructured":"Jahangiry, L. et al. Modifiable lifestyle risk factors and metabolic syndrome: opportunities for a web-based preventive program. Journal of research in health sciences 14(4), 303\u2013307 (2014).","DOI":"10.1186\/1471-2458-14-748"},{"issue":"13","key":"44486_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.6026\/97320630008613","volume":"8","author":"SH Beigh","year":"2012","unstructured":"Beigh, S. H. et al. Prevalence of metabolic syndrome and gender differences. Bioinformation. 8(13), 613\u20136 (2012).","journal-title":"Bioinformation."},{"issue":"2(1)","key":"44486_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-5996-2-1","volume":"12","author":"AO Ogbera","year":"2010","unstructured":"Ogbera, A. O. et al. Prevalence and gender distribution of the metabolic syndrome. Diabetology & Metabolic Syndrome. 12(2(1)), 1 (2010).","journal-title":"Diabetology & Metabolic Syndrome."},{"key":"44486_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/jhh.2011.106","volume":"27","author":"M Novak","year":"2011","unstructured":"Novak, M. et al. Gender differences in the prevalence of metabolic syndrome in 50-year-old Swedish men and women with hypertension born in 1953. Journal Of Human Hypertension. 27, 56 (2011).","journal-title":"Journal Of Human Hypertension."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44486-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44486-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44486-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:59:29Z","timestamp":1671271169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44486-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["44486"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-44486-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"12 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7937"}}